Fundacao Dr.Amaral Carvalho

Jaú, São Paulo CEP: 17210-080

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Cancer of the Prostate, Endometrial Neoplasms, HER2 Positive Breast Cancer, Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — Completed
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab — Stopped early